IPO

The timing and pricing of the Seattle company's IPO are yet to be determined.

While the tech-enabled primary care provider set the initial pricing of its shares at $14 apiece, prices are climbing in the early hours of its IPO.

Rock Health's annual funding report revealed that the average size of digital health deals decreased in 2019, as did the total funding for the year. 

According to a Wall Street Journal report, the digital chronic disease management company is eyeing a $1B-plus valuation.

Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.

Health Catalyst CEO Dan Burton Utah-based data warehouse company Health Catalyst is frequently mentioned as a candidate for the next digital health IPO, and CEO Dan Burton coyly addressed that chatter from the stage at Health 2.

Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.

BodyMedia's patents, now owned by Jawbone, are at the heart of the new suit.

Jawbone's UP2 device Some 20 percent of investors said they expect Jawbone to go public this year, according to a Rock Health survey of 43 investors.

Teladoc, a large and fast-growing video visits company based in Dallas, Texas, has taken the first step toward filing an initial public offering, according to a statement from the company.